Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
amyloid/slagtilfælde
Linket gemmes på udklipsholderen
Side 1 fra 26 resultater
Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of Alzheimer's disease (AD)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to (1) phenolic ester hybrids of niacin with m-methoxy-p-hydroxy phenyl compounds like eugenol, vanillin, apocynin, ferulic acid, isoferulic acid and eugenol epoxide and (2) cocrystals of hybrids as above, particularly cocrystal of niacin-eugenol
5,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to novel 5,6-dihydro-2H-[1,4]oxazin-3-ylamine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions comprising
4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of PCT Application No. PCT/EP2011/066343, filed Sep. 20, 2011, which claims priority from European Patent Application No. 10178315.7, filed Sep. 22, 2010 and European Patent Application No. 11157858.9, filed Mar. 11,
6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of PCT Application No. PCT/EP2012/053455, filed Feb. 29, 2012, which claims priority from European Patent Application No. 11156463.9, filed Mar. 1, 2011, the entire disclosures of which are hereby incorporated in their
Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national phase application, under 35 U.S.C. 371, of international application No. PCT/KR2009/007898, filed on Dec. 29, 2009, which claimed priority to Korean Patent Application No. 10-2008-0135519, filed on Dec. 29, 2008, the disclosures
Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitors
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of PCT Application No. PCT/EP2012/053863 filed Mar. 7, 2012, which claims priority from European Patent Application No. 11157418.2, filed Mar. 9, 2011, the entire disclosures of which are hereby incorporated in their
5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to novel 5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives as inhibitors of beta-secretase, also known as beta-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2. The invention is also directed to pharmaceutical compositions
4-Amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2H)-one derivatives as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICARIONS
This application is the national stage of PCT Application No. PCT/EP2014/062283, filed Jun. 12, 2014, which claims priority from European Patent Application No. 13171723.3,filed Jun. 12, 2013, the entire disclosures of which are hereby incorporated in their
4-amino-6-phenyl-5,6-dihydroimidazo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of PCT Application No. PCT/EP2014/062285, filed Jun. 12, 2014, which claims priority from European Patent Application No. 13171730.8, filed Jun. 12, 2013, the entire disclosures of which are hereby incorporated in their
4-amino-6-phenyl-6,7-dihydro[1,2,3]triazolo[1,5-A]pyrazine derivatives as inhibitors of beta-secretase (BACE)
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of PCT Application No. PCT/EP2014/062286, filed Jun. 12, 2014, which claims priority from European Patent Application No. 13171720.9, filed Jun. 12, 2013, the entire disclosures of which are hereby incorporated in their
Compound inhibiting activation of the enzyme Erk 1/2 to be used in the treatment of neurodegenerative illnesses
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention belongs to the field of medical chemistry and relates to the compound of formula (I), a primary triclyclic amine, which inhibits the tPA-induced activation of the enzyme Erk 1/2 and is promising for, the treatment of neurodegenerative illnesses, such as,
Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
The present invention relates to novel tricyclic sulfonamide compounds and their derivatives useful as pharmaceutical agents, to methods for their production, to pharmaceutical compositions which include these compounds and a pharmaceutically acceptable carrier, and to
Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
The present invention relates to novel tricyclic sulfonamide compounds and their derivatives useful as pharmaceutical agents, to methods for their production, to pharmaceutical compositions which include these compounds and a pharmaceutically acceptable carrier, and to
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the national stage of PCT Application No. PCT/EP2015/079981, filed Dec. 16, 2015, which claims priority from European Patent Application No. 14198977.2, filed Dec. 18, 2014 and European Patent Application No. 15164704.7, filed Apr. 22,
Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
The present invention relates to novel biphenyl butyric acid compounds and their derivatives useful as pharmaceutical agents, to methods for their production, to pharmaceutical compositions which include these compounds and a pharmaceutically acceptable carrier, and to
Den mest komplette database med medicinske urter understøttet af videnskab
- Arbejder på 55 sprog
- Urtekurer, der understøttes af videnskab
- Urtegenkendelse ved billede
- Interaktivt GPS-kort - tag urter på stedet (kommer snart)
- Læs videnskabelige publikationer relateret til din søgning
- Søg medicinske urter efter deres virkninger
- Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter
Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning
